MP29-02*'s advanced delivery system contributes to its efficacy in patients with moderate/severe seasonal allergic rhinitis. Issue 4 (December 2015) - Scadding, Glenis; Bachert, Claus; Hellings, Peter; Fokkens, Wytske; Munzel, Ullrich; Mösges, Ralph